Skip to content

Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years

A Randomized Crossover Study to Evaluate Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01373177
Enrollment
119
Registered
2011-06-14
Start date
2011-01-31
Completion date
2015-02-28
Last updated
2019-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Development

Brief summary

The objective of this randomized study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III (Bayley-III) are higher than scores on the Bayley Scales of Infant Development-II (BSID-II) in the same group of infants who were born very preterm.

Detailed description

The objective of this randomized crossover study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III are higher than scores on the Bayley Scales of Infant Development-II in the same group of infants who were born very preterm. First, however, the investigators must demonstrate that significant learning does not occur when the tests are administered 4-8 weeks apart. The investigators hypothesize that scores on the Bayley-III will be higher than scores on the BSID-II, irrespective of the order in which the tests are administered.

Interventions

DIAGNOSTIC_TESTBayley Scales of Infant Development-II

Individually administered test, designed to evaluate the developmental functioning of infants and small children, between 1 and 42 months of age. The purpose of the test is to identify infants and children with developmental delay. BSID-II was published in 1993. BSID-II provides normative data from two scales - Mental Development Index (MDI), and Psychomotor Development Index (PDI).

DIAGNOSTIC_TESTBayley Scales of Infant Development-III

Individually administered test, designed to evaluate the developmental functioning of infants and small children, between 1 and 42 months of age. The purpose of the test is to identify infants and children with developmental delay. BSID-III was released in 2006. BSID-III provides normative data from five scales - Cognitive, Language, Motor, Social-Emotional, and Adaptive.

Sponsors

University of Pennsylvania
CollaboratorOTHER
Children's Hospital of Philadelphia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Months to 22 Months
Healthy volunteers
Yes

Inclusion criteria

* Birth weight \<2000 grams and \<32 weeks * Corrected age of 18-22 months.

Exclusion criteria

* English is not the primary language in the child's home. * Parent is unable to give informed consent for research participation. * Parent is unable to commit to returning for follow-up testing in 4-8 weeks. * Infant has severe medical illness or disability expected to impact his/her ability to participate in testing (ex: blindness, deafness, severe cerebral palsy, autism, tracheostomy). * No exclusion for economic status, gender, race or ethnicity. * Participation in a RCT that restricts timing and administration of developmental testing.

Design outcomes

Primary

MeasureTime frame
The primary outcome is the mean difference between BSID-II Mental Development Index (MDI) and Bayley-III Cognitive Score.18-22 months

Secondary

MeasureTime frame
Mean difference between BSID-II Physical Development Index and Bayley-III Composite Motor Score.18-22 months
Proportion of infants classified as having developmental delay (MDI <70 on BSID-II or either Language or Cognitive Score <70 on the Bayley-III).18-22 months
The mean difference in scores between time point one and time point two (a measure of learning or training).18-22 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026